Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2880 Target Snapshot

Adenylate cyclase type 5 · SINGLE PROTEIN · Rattus norvegicus

36Compounds
36Assays
1Approved Drugs
34.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q04400. Use UniProt Q04400 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q04400 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Adenylate cyclase type 5 as ChEMBL target CHEMBL2880, mapped to UniProt Q04400. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Adenylate cyclase type 5
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL2880
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q04400
Adenylate cyclase type 5
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Adenylate cyclase type 5 is the right protein anchor across sources, using UniProt Q04400 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAdenylate cyclase type 5
UniProt AccessionQ04400
Component TypeProtein
Sequence Length1262 aa

Adenylate cyclase type 5

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Adenylate cyclase type 5, mapped to UniProt Q04400. Sequence length is 1262 aa.

Mapped IDQ04400
Review nameAdenylate cyclase type 5
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5012.0
EC5022.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL25856 8.67 EC50 2.15 Clinical
CHEMBL320428 8.0 EC50 10.0 Preclinical
CHEMBL318338 8.0 EC50 10.0 Preclinical
CHEMBL319707 6.94 EC50 114.0 Preclinical
CHEMBL106801 6.89 EC50 130.0 Preclinical
CHEMBL104772 6.87 EC50 134.0 Preclinical
CHEMBL106836 6.83 EC50 148.0 Preclinical
CHEMBL106116 6.82 EC50 151.0 Preclinical
CHEMBL13078 6.56 EC50 275.0 Preclinical
CHEMBL104141 6.48 EC50 333.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
3
5.5
5
6.0
8
6.5
2
7.0
0
7.5
2
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

36
Total Assays
21
Tested Compounds
2
Assay Types
Binding — 31 assays, 21 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 14 10 7.0
cell-based format 12 0
single protein format 3 1 7.6
cell membrane format 1 4 6.1
tissue-based format 1 6 5.2
Functional — 5 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-free format 2 0
cell membrane format 1 1 7.3
cell-based format 1 0
tissue-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine